Price (delayed)
$117.56
Market cap
$14.13B
P/E Ratio
53.19
Dividend/share
$0.28
EPS
$2.21
Enterprise value
$16.27B
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.